Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Research Using Human Pluripotent Stem Cells and Organoids

24 Jul 2021

Abstract excerpt

Experimental cell models are indispensable for clarifying the pathophysiology of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and for developing therapeutic agents. To recapitulate the symptoms and drug response of COVID-19 patients in vitro, SARS-CoV-2 studies using physiologically relevant human embryonic stem (ES)/induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ethics and Legal Issues in Pediatric Healthcare
Share to Pluripotent Stem Cells Research
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34302450
DOI: 10.1002/sctm.21-0183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Research Using Human Pluripotent Stem Cells and OrganoidsPMID 34302450Read ↗

Application of Human Induced Pluripotent Stem Cell-Derived Cellular and Organoid Models for COVID-19 ResearchSemantic proximity Read ↗

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and OrganoidsSemantic proximity Read ↗

Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 NeurotropismSemantic proximity Read ↗

Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral OrganoidsSemantic proximity Read ↗

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read ↗

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal OrganoidsSemantic proximity Read ↗

Recent Advances of COVID-19 Modeling Based on Regenerative MedicineSemantic proximity Read ↗

Human Pluripotent Stem Cell Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory ResponseSemantic proximity Read ↗

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Semantic proximity Read ↗

Induced pluripotent stem cells for modelling human diseasesSemantic proximity Read ↗

Organ-Specific Treatment for COVID-19: Rationale, Evidence, and Potential CandidatesSemantic proximity Read ↗

Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.